These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10468096)

  • 1. Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension.
    Hinderliter AL; Willis PW; Long W; Clarke WR; Ralph D; Caldwell EJ; Williams W; Ettinger NA; Hill NS; Summer WR; de Biosblanc B; Koch G; Li S; Clayton LM; Jöbsis MM; Crow JW
    Am J Cardiol; 1999 Aug; 84(4):481-4, A10. PubMed ID: 10468096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension.
    Raymond RJ; Hinderliter AL; Willis PW; Ralph D; Caldwell EJ; Williams W; Ettinger NA; Hill NS; Summer WR; de Boisblanc B; Schwartz T; Koch G; Clayton LM; Jöbsis MM; Crow JW; Long W
    J Am Coll Cardiol; 2002 Apr; 39(7):1214-9. PubMed ID: 11923049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.
    Sitbon O; Humbert M; Nunes H; Parent F; Garcia G; Hervé P; Rainisio M; Simonneau G
    J Am Coll Cardiol; 2002 Aug; 40(4):780-8. PubMed ID: 12204511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term continuous intravenous infusion of prostacyclin for severe primary pulmonary hypertension.
    Okano Y; Senju S; Tsutsui Y; Kyotani S; Ishibashi M; Yoshida M; Kunieda T
    Intern Med; 1997 Nov; 36(11):794-8. PubMed ID: 9392352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage.
    Fenstad ER; Le RJ; Sinak LJ; Maradit-Kremers H; Ammash NM; Ayalew AM; Villarraga HR; Oh JK; Frantz RP; McCully RB; McGoon MD; Kane GC
    Chest; 2013 Nov; 144(5):1530-1538. PubMed ID: 23949692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.
    McLaughlin VV; Shillington A; Rich S
    Circulation; 2002 Sep; 106(12):1477-82. PubMed ID: 12234951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension.
    Shimony A; Fox BD; Langleben D; Rudski LG
    Can J Cardiol; 2013 Jun; 29(6):678-82. PubMed ID: 22717247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
    Montalescot G; Drobinski G; Meurin P; Maclouf J; Sotirov I; Philippe F; Choussat R; Morin E; Thomas D
    Am J Cardiol; 1998 Sep; 82(6):749-55. PubMed ID: 9761085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Pericardial Effusion on Serial Echocardiograms in Pulmonary Arterial Hypertension.
    Batal O; Dardari Z; Costabile C; Gorcsan J; Arena VC; Mathier MA
    Echocardiography; 2015 Oct; 32(10):1471-6. PubMed ID: 25682779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion.
    Shapiro SM; Oudiz RJ; Cao T; Romano MA; Beckmann XJ; Georgiou D; Mandayam S; Ginzton LE; Brundage BH
    J Am Coll Cardiol; 1997 Aug; 30(2):343-9. PubMed ID: 9247503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients.
    Hsu HH; Chen JS; Kuo SH; Chiang FT; Ko WJ; Kuo SW; Huang SC; Lee YC
    J Formos Med Assoc; 2005 Jan; 104(1):60-3. PubMed ID: 15660181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoprostenol in chronic thromboembolic pulmonary hypertension with distal lesions.
    Scelsi L; Ghio S; Campana C; D'Armini AM; Serio A; Klersy C; Piovella F; Viganò M; Tavazzi L
    Ital Heart J; 2004 Aug; 5(8):618-23. PubMed ID: 15554033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension complicated by pericardial effusion: a single center experience.
    Honeycutt GR; Safdar Z
    Ther Adv Respir Dis; 2013 Jun; 7(3):151-9. PubMed ID: 23258502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic management of primary pulmonary hypertension].
    Chaouat A; Weitzenblum E
    Presse Med; 2002 Feb; 31(7):320-8. PubMed ID: 11899690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of nesiritide vs. epoprostenol in a patient with precapillary pulmonary hypertension due to scleroderma complicated by postcapillary pulmonary hypertension.
    Zakir RM; Berkowitz RL; Saric M; Ashtyani H
    Congest Heart Fail; 2005; 11(6):331-4. PubMed ID: 16330910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperuricemia in severe pulmonary hypertension.
    Voelkel MA; Wynne KM; Badesch DB; Groves BM; Voelkel NF
    Chest; 2000 Jan; 117(1):19-24. PubMed ID: 10631193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous administration of a low dose of epoprostenol greatly decreased serum concentrations of endothelin-1 in primary pulmonary hypertension--a case report.
    Kakinuma Y; Honma S; Morimoto T; Maruyama H; Yamazaki A; Ishimitsu T; Yamaguchi I
    Angiology; 2005; 56(5):641-5. PubMed ID: 16193207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol infusion].
    Cao TS; Yuan LJ; Duan YY; Wang ZJ; Zhuang L; Shapiro SM; Brundage BH
    Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):106-9. PubMed ID: 12783707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.
    Frost AE; Quiñones MA; Zoghbi WA; Noon GP
    J Heart Lung Transplant; 2005 Apr; 24(4):501-3. PubMed ID: 15797757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic intractable pericardial effusion associated with pulmonary hypertension: report of two cases].
    Iwasaki K; Kusachi S; Nishiyama O; Ueda M; Kita T; Haraoka S
    Kokyu To Junkan; 1990 Jul; 38(7):709-12. PubMed ID: 2402575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.